AVE1642
Product Specifications
Target
IGF-1R
Related Pathways
Tyrosine Kinase/Adaptors
Bioactivity
AVE1642 is a human IgG monoclonal antibody (mAb) that specifically targets CD221/IGF1R. It has the ability to slow the growth of tumor xenografts and extend the survival of tumor-bearing nude mice. AVE1642 is applicable in the study of advanced solid tumors. Recommended isotype control: HumanIgG1kappa, Isotype Control.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
DFA09087-01 50 mg
2- (2-Amino-3-methylbutanamido) -3-phenylpropanoic acid hydrochloride
Sign In for Pricing
View Details DFA09087-02 0.5 g
2- (2-Amino-3-methylbutanamido) -3-phenylpropanoic acid hydrochloride
Sign In for Pricing
View Details 
orb3005233-01 20 µg
Recombinant Human Choriogonadotropin subunit beta 3 (CGB3)
Sign In for Pricing
View Details orb3005233-02 100 µg
Recombinant Human Choriogonadotropin subunit beta 3 (CGB3)
Sign In for Pricing
View Details orb3005233-03 1 mg
Recombinant Human Choriogonadotropin subunit beta 3 (CGB3)
Sign In for Pricing
View Details